Tech Company Financing Transactions
Rodeo Therapeutics Funding Round
Rodeo Therapeutics, based in Seattle, secured $5.9 million in funding from AbbVie Biotech Ventures, Accelerator Ventures and Alexandria Venture Investments.
Transaction Overview
Company Name
Announced On
7/26/2017
Transaction Type
Venture Equity
Amount
$5,900,000
Round
Series A
Investors
Proceeds Purpose
We believe that this Series A investment will provide the financial resources to rapidly advance the company's development program toward human trials, which will open the door to an exciting new therapeutic approach that has significant clinical and commercial potential.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2815 Eastlake Ave. E 300
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Overview
Rodeo Therapeutics is focused on developing small-molecule therapies that increase tissue levels of prostaglandin PGE2.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Stanton Gerson
Founder
Sanford Markowitz
Founder
Joseph Ready
Browse more venture capital transactions:
Prev: 7/25/2017: Hinge Health venture capital transaction
Next: 7/26/2017: Maven venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs